ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 137 filers reported holding ABCELLERA BIOLOGICS INC in Q3 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,002,624 | -39.5% | 435,353 | -15.1% | 0.00% | -33.3% |
| Q2 2023 | $3,312,707 | -70.1% | 512,803 | -65.1% | 0.00% | -75.0% |
| Q1 2023 | $11,071,706 | -55.3% | 1,468,396 | -40.0% | 0.01% | -55.6% |
| Q4 2022 | $24,792,203 | -9.7% | 2,447,404 | -11.8% | 0.03% | -18.2% |
| Q3 2022 | $27,448,000 | +133.8% | 2,775,359 | +151.7% | 0.03% | +135.7% |
| Q2 2022 | $11,742,000 | +4034.5% | 1,102,520 | +3689.1% | 0.01% | – |
| Q1 2022 | $284,000 | -93.2% | 29,097 | -90.0% | 0.00% | -100.0% |
| Q4 2021 | $4,157,000 | -17.1% | 290,711 | +16.1% | 0.00% | 0.0% |
| Q3 2021 | $5,016,000 | – | 250,293 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Founders Fund VII Management, LLC | 3,773,530 | $37,320,000 | 92.58% |
| Gruss & Co., LLC | 308,570 | $3,052,000 | 26.27% |
| Founders Fund Growth Management, LLC | 407,017 | $4,025,000 | 11.55% |
| Belmont Capital, LLC | 510,000 | $5,044,000 | 5.95% |
| HARVARD MANAGEMENT CO INC | 4,105,095 | $40,599,000 | 5.05% |
| GUARDIAN CAPITAL ADVISORS LP | 3,736,414 | $40,129,000 | 5.01% |
| Intellectus Partners, LLC | 1,091,505 | $10,795,000 | 3.84% |
| ArchPoint Investors | 617,213 | $6,104,000 | 2.49% |
| BRANDYWINE MANAGERS, LLC | 56,976 | $563,000 | 1.85% |
| Casdin Capital, LLC | 1,650,000 | $16,319,000 | 1.07% |